| |
| |
|
| Insider
Information: |
Armen Garo H |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
6,235,576 |
|
|
Indirect Shares
|
310,248 |
|
|
| Direct
Value |
$30,955 |
|
|
|
Indirect Value
|
$26,720 |
|
|
| Total
Shares |
6,545,824 |
|
|
| Total
Value |
$57,675 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -32.2%
|
-74.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Color Kinetics Inc |
CLRK |
Director |
2007-08-24 |
0 |
2007-08-24 |
0 |
Premium* |
|
|
Antigenics Inc |
AGEN |
|
2024-04-19 |
69,797 |
2024-04-19 |
60,248 |
Premium* |
|
|
Protagenic Therapeutics Ord Shs |
PTIX |
See Remarks, Director,... |
2016-06-17 |
4,299,379 |
2016-02-12 |
250,000 |
Premium* |
|
|
Mink Therapeutics, Inc. |
INKT |
|
2023-05-05 |
1,866,400 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2024-04-19 |
4 |
A |
$5.31 |
$16,355 |
D/D |
3,080 |
69,797 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2024-04-05 |
4 |
A |
$0.50 |
$16,349 |
D/D |
32,697 |
1,335,325 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2024-03-22 |
4 |
A |
$0.55 |
$14,940 |
D/D |
27,163 |
1,302,628 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2024-03-08 |
4 |
A |
$0.67 |
$14,831 |
D/D |
22,136 |
1,275,465 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2024-02-23 |
4 |
A |
$0.68 |
$14,834 |
D/D |
21,815 |
1,253,329 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2024-02-15 |
4 |
B |
$0.65 |
$324,050 |
I/I |
500,000 |
625,969 |
0.01 |
% |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2024-02-09 |
4 |
A |
$0.75 |
$14,834 |
D/D |
19,778 |
1,231,514 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2024-01-26 |
4 |
A |
$0.66 |
$14,834 |
D/D |
22,475 |
1,211,736 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2024-01-12 |
4 |
A |
$0.64 |
$14,833 |
D/D |
23,177 |
1,439,261 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2023-12-29 |
4 |
A |
$0.83 |
$19,466 |
D/D |
23,453 |
1,416,084 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2023-12-15 |
4 |
A |
$0.69 |
$16,183 |
D/D |
23,453 |
1,396,538 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2023-12-01 |
4 |
A |
$0.78 |
$16,167 |
D/D |
20,727 |
1,373,085 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2023-11-17 |
4 |
A |
$0.69 |
$16,223 |
D/D |
23,511 |
1,352,358 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2023-11-03 |
4 |
A |
$0.84 |
$16,128 |
D/D |
19,200 |
1,328,847 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2023-10-20 |
4 |
A |
$0.89 |
$16,146 |
D/D |
18,142 |
1,309,647 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2023-10-06 |
4 |
A |
$1.06 |
$16,223 |
D/D |
15,305 |
1,291,505 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2023-09-22 |
4 |
A |
$1.18 |
$16,388 |
D/D |
13,888 |
1,276,200 |
0 |
- |
|
| AGEN |
Antigenics Inc |
See Remarks |
• • – |
2023-09-08 |
4 |
A |
$1.23 |
$16,168 |
D/D |
13,145 |
1,262,312 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
|
– • – |
2023-05-05 |
4 |
S |
$0.95 |
$94,850 |
D/D |
(100,000) |
1,866,400 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
|
– • – |
2023-05-02 |
4 |
B |
$0.95 |
$94,850 |
D/D |
100,000 |
1,978,010 |
0.01 |
- |
|
| AGEN |
Antigenics Inc |
Chairman and CEO |
• • – |
2023-01-05 |
4 |
A |
$2.45 |
$591,388 |
D/D |
241,383 |
1,249,167 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chairman and CEO |
• • – |
2022-02-02 |
4 |
A |
$2.51 |
$594,898 |
D/D |
237,011 |
1,007,784 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Director |
– • – |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,226,400 |
|
- |
|
| AGEN |
Antigenics Inc |
Chairman and CEO |
• • – |
2021-09-13 |
4 |
S |
$6.50 |
$533,696 |
D/D |
(82,107) |
770,773 |
0 |
% |
|
| AGEN |
Antigenics Inc |
Chairman and CEO |
• • – |
2021-09-13 |
4 |
OE |
$3.36 |
$400,438 |
D/D |
119,178 |
852,880 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
